A publication titled "Efficacy and safety of terlipressin infusion during liver surgery: a meta-analysis" appeared in the journal Updates in Surgery, dated September 1, 2026. The entry is indexed on PubMed under ID 40240682.
This is a meta-analysis, meaning it compiles and evaluates data from multiple existing studies rather than presenting new original research. The publication record identifies the topic as terlipressin infusion used during liver surgery, examining both efficacy and safety as reported in the source literature.
No specific findings, outcomes, or conclusions from the meta-analysis are included in this brief, as that level of detail was not provided in the event data. Readers interested in the specific results, methodology, or statistical outcomes reported in the meta-analysis should consult the full text through the journal or the PubMed listing directly.
It should be noted that lypressin, the compound associated with this listing, carries an unapproved research status. This publication concerns terlipressin, a related vasopressin analog, and its use in a surgical context. For general background on lypressin, readers can consult the compound overview page.